Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions is a research paper published in Antibodies (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R35 CA210039
National Institutes of Health
Grant: R15 CA242351
National Institutes of Health
Grant: T32 CA082084
National Institutes of Health
Grant: F32 CA236457
National Institutes of Health
Grant: PF LIB 125429
National Institutes of Health
Grant: NIH S10OD019942-01
National Institutes of Health
Grant: NIH S10OD011925-01
NIH HHS
Grant: S10 OD011925
NIH HHS
Grant: S10 OD019942
University of Pittsburgh Medical Center (UPMC) Immune Transplant and Therapy Center (ITTC)
Grant: NA
NCI NIH HHS
Grant: P30 CA047904
National Institutes of Health
Grant: 2T32CA082084-21A1
Cancer Immunology Training Program
National Institutes of Health
Grant: 1S10OD011925-01
Special BD LSRFortessaTM
National Institutes of Health
Grant: 1S10OD019942-01
ImageStreamX MarkII
National Institutes of Health
Grant: 5F32CA236457-02
Effector mechanisms and therapeutic potential of MUC1 vaccine-elicited human antibodies
National Institutes of Health
Grant: 2R15CA242351-02
Mechanistic insight into tumor-associated MUC1 glycopeptides binding to macrophage galactose-type lectin
National Institutes of Health
Grant: 1R35CA210039-01
Immunoprevention and immunosurveillance of human non-viral cancers
University of Pittsburgh Medical Center Immune Transplant and Therapy Center
FWCI
0.80
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals